Arthritis, Musculoskeletal and Skin Diseases Research in New Jersey
Arthritis, Musculoskeletal and Skin Diseases Research (93.846) awarded $17.5 million to recipients in New Jersey in 22 grants from fiscal 2021 to 2025, 0.7% of the program's national total. The Trustees of Princeton University received the most, $7.1 million.
- Awarded in New Jersey$17.5 million
- Awards22
- Share of the program0.7%
- Rank among states28th of 44
- National total$2.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 9 | $4.1 million |
| FY 2022 | 13 | $3.5 million |
| FY 2023 | 7 | $2.1 million |
| FY 2024 | 9 | $2.0 million |
| FY 2025 | 10 | $5.8 million |
Recipients in New Jersey
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Trustees of Princeton University | Colleges and universities | 6 | $7.1 million |
| Rutgers the State University of New Jersey | Colleges and universities | 7 | $4.6 million |
| Regenosine, Inc. | Small businesses | 2 | $2.5 million |
| Novopedics Inc | Small businesses | 2 | $1.3 million |
| New Jersey Institute of Technology | Colleges and universities | 3 | $1.2 million |
| Rowan University | Colleges and universities | 1 | $475,680 |
| Ru School of Osteopathic Medicine | Colleges and universities | 1 | $365,880 |
Open opportunities under this program
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)
- NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
- Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)
See all 60 on the program page
Questions people ask
How much Arthritis, Musculoskeletal and Skin Diseases Research money goes to New Jersey?
$17.5 million from fiscal 2021 to 2025, across 22 awards. New Jersey ranks 28th of 44 states and territories for this program.
Who receives Arthritis, Musculoskeletal and Skin Diseases Research money in New Jersey?
The largest recipient is The Trustees of Princeton University, with $7.1 million in 6 awards. Next are Rutgers the State University of New Jersey and Regenosine, Inc..
Can organizations in New Jersey apply now?
Yes, 60 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Arthritis, Musculoskeletal and Skin Diseases Research in other states
Other large programs in New Jersey
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Federal Transit Formula Grants
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Children's Health Insurance Program
- Special Education Grants to States
- 1332 State Innovation Waivers
- Title I Grants to Local Educational Agencies